SCHEMBL7646830

SCHEMBL7646830

CC(=O)NC(N)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11555339 0.77 — —
SCHEMBL12261418 0.72 — —
SCHEMBL22872710 0.71 — —
SCHEMBL2920884 0.70 — —
SCHEMBL6618896 0.70 — —
SCHEMBL4044697 0.70 — —
SCHEMBL13454973 0.70 — —
SCHEMBL404105 0.69 — —
SCHEMBL16814812 0.67 — —
SCHEMBL15094372 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183023-A1 USE OF VERAPAMIL AND VERAPAMIL DERIVATIVES FOR PRODUCING MEDICAMENTS WITH AN INHIBITING EFFECT ON BETA-GLUCURONIDASE IN HUMAN TISSUE PAZ ARZNEIMITTEL- ENTWICKLUNGSGESELLSCHAFT MBH (DE) 2002-03-06 — — EP disclosed
WO-2000074670-A1 USE OF VERAPAMIL AND VERAPAMIL DERIVATIVES FOR PRODUCING MEDICAMENTS WITH AN INHIBITING EFFECT ON β-GLUCURONIDASE IN HUMAN TISSUE PAZ ARZNEIMITTEL-ENTWICKLUNGS GESELLSCHAFT MBH (DE) 2000-12-14 — — WO disclosed
Send feedback